Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary CNS Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01448096
What this trial is testing

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse Lymphoma
Chonbuk National University Hospital 33
Not applicableStudy completedNCT00416819
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Testing effectiveness (Phase 2)Ended earlyNCT00072449
What this trial is testing

Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)UnknownNCT04938297
What this trial is testing

Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Henan Cancer Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04066920
What this trial is testing

IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma
Deok-Hwan Yang 30
Testing effectiveness (Phase 2)Looking for participantsNCT04906096
What this trial is testing

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

Who this might be right for
Primary Central Nervous System LymphomaNon-Hodgkin Lymphoma of Extranodal Site
Lakshmi Nayak, MD 25
Not applicableEnded earlyNCT00710151
What this trial is testing

Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
OHSU Knight Cancer Institute 80
Testing effectiveness (Phase 2)UnknownNCT02983942
What this trial is testing

Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Beijing Tiantan Hospital 50
Not applicableStudy completedNCT03188354
What this trial is testing

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinCentral Nervous System Neoplasms
Norwegian University of Science and Technology 3
Testing effectiveness (Phase 2)WithdrawnNCT00003929
What this trial is testing

Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT03703167
What this trial is testing

Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL)

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00082836
What this trial is testing

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT03569995
What this trial is testing

[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

Who this might be right for
Primary CNS Lymphoma
Won Seog Kim 35
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Study completedNCT03495960
What this trial is testing

Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Who this might be right for
Primary Central Nervous System Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 72
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT04037189
What this trial is testing

Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia

Who this might be right for
Ataxia TelangiectasiaLeukemiaLymphoma
Rabin Medical Center 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06901999
What this trial is testing

Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Who this might be right for
CNS Lymphoma
Ruijin Hospital 23
Not applicableStudy completedNCT00416312
What this trial is testing

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Next Page